American Family and Cox Enterprises have helped the digital insurance provider reach a unicorn valuation and take its overall funding to $329m.

Vision Fund 2 participated in a series B round for the gene therapy developer, formed through the 2019 merger of Torque Therapeutics and Cogen Immune Medicine.

Gene therapy developer Jaguar has completed a series B round co-led by Eli Lilly and Deerfield Management.

The personalised dental care provider increased its overall funding to almost $200m in a GV-backed series C round.

The drug discovery platform developer will support its growth with new funding from investors including SIG and Legend Capital.

The oncology drug developer, backed by Bristol Myers Squibb, secured close to $144m in its IPO. This is an exit from a space that has seen much corporate support over the past decade.

RA Capital has led a $100m series B round for Ventus Therapeutics, which is linked to multiple universities.

The SoftBank-backed robotic technology developer has secured series B-plus funding two months after US regulators deemed its initial public offering abandoned.

Stripe led a $50m second tranche for the corporate charge card provider's latest round, which valued it at $1.6bn.

Starr Insurance and Liberty Mutual Insurance are among the insurance providers that have backed the Bitcoin custodian services provider in its latest round.